Joseph P. Hagan, Chief Executive Officer at Regulus Therapeutics Inc. (RGLS), sold 242,344 shares at $1.26 ($305K) on 2025-01-13, disclosed to the SEC on 2025-01-15.
Scheduled sale ($305k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.26 | 115,290 | $145K | 47.6% |
| 2 | $1.26 | 115,290 | $145K | 47.6% |
| 3 | $1.26 | 11,764 | $15K | 4.9% |
| Total | $1.26 avg | 242,344 | $305K | 100% |
| Filing → |
| AUPH | SELL | 2023-05-23 | $3K | — | Filing → |
| RGLS | BUY | 2022-01-26 | $22K | — | Filing → |
| AUPH | SELL | 2022-01-04 | $1.8M | — | Filing → |